Cargando…

Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth

INTRODUCTION: The transcription factor GATA3 is involved in mammary gland development and is crucial for the maintenance of the differentiated status of luminal epithelial cells. The role of GATA3 in breast cancer as a tumor suppressor has been established, although insights into the mechanism of GA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izzo, Franco, Mercogliano, Florencia, Venturutti, Leandro, Tkach, Mercedes, Inurrigarro, Gloria, Schillaci, Roxana, Cerchietti, Leandro, Elizalde, Patricia V, Proietti, Cecilia J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303201/ https://www.ncbi.nlm.nih.gov/pubmed/25479686 http://dx.doi.org/10.1186/s13058-014-0491-x

Ejemplares similares

ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022)

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
por: Rivas, Martin A, et al.
Publicado: (2012)

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer
por: Mercogliano, María F., et al.
Publicado: (2017)

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
por: Díaz Flaqué, María C, et al.
Publicado: (2013)

Retraction Note: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
por: Flaqué, María C. Díaz, et al.
Publicado: (2023)

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2020)

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
por: Mercogliano, María Florencia, et al.
Publicado: (2021)

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression
por: Bruni, Sofia, et al.
Publicado: (2023)

Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy
por: De Martino, Mara, et al.
Publicado: (2020)

ODP551 Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple Negative Breast Cancer
por: Elizalde, Patricia Virginia, et al.
Publicado: (2022)

Emerging Targeted Therapies for HER2-Positive Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2023)

Halting Retrograde Transport Excludes ErbB-2 From the Nucleus Abrogating Tumor Growth in Triple Negative Breast Cancer
por: Madera, Santiago, et al.
Publicado: (2021)

Cancer immune exclusion: breaking the barricade for a successful immunotherapy
por: Bruni, Sofia, et al.
Publicado: (2023)

Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model
por: Durfort, Tiphanie, et al.
Publicado: (2012)

Friend of GATA-1 Represses GATA-3–dependent Activity in CD4(+) T Cells
por: Zhou, Meixia, et al.
Publicado: (2001)

SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes
por: Madera, Santiago, et al.
Publicado: (2020)

ODP441 NErbB-2 and Androgen Receptor Regulate a Gene Signature Involved in Immune Response and Favorable Outcome in TNBC
por: Elizalde, Patricia, et al.
Publicado: (2022)

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
por: Madera, Santiago, et al.
Publicado: (2022)

Transcriptional Repression of Gata3 Is Essential for Early B Cell Commitment
por: Banerjee, Anupam, et al.
Publicado: (2013)

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
por: Schillaci, Roxana, et al.
Publicado: (2012)

GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm
por: Castaño, Julio, et al.
Publicado: (2019)

GATA4 negatively regulates osteoblast differentiation by downregulation of Runx2
por: Song, Insun, et al.
Publicado: (2014)

OsGATA16, a GATA Transcription Factor, Confers Cold Tolerance by Repressing OsWRKY45–1 at the Seedling Stage in Rice
por: Zhang, Hongjia, et al.
Publicado: (2021)

Bone turnover after bariatric surgery
por: Melo, Thalita Lima, et al.
Publicado: (2017)

A Single cis Element Maintains Repression of the Key Developmental Regulator Gata2
por: Snow, Jonathan W., et al.
Publicado: (2010)

SUMOylation Regulates the Transcriptional Repression Activity of FOG-2 and Its Association with GATA-4
por: Perdomo, José, et al.
Publicado: (2012)

Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation
por: Guo, Yidi, et al.
Publicado: (2015)

Progesterone effects on the oligodendrocyte linage: all roads lead to the progesterone receptor
por: Jure, Ignacio, et al.
Publicado: (2019)

ROS-Induced GATA4 and GATA6 Downregulation Inhibits StAR Expression in LPS-Treated Porcine Granulosa-Lutein Cells
por: Qu, Xiaolu, et al.
Publicado: (2019)

Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover
por: Adomas, Aleksandra B, et al.
Publicado: (2014)

Give progesterone a chance
por: Labombarda, Florencia, et al.
Publicado: (2014)

GATA elements control repression of cardiac troponin I promoter activity in skeletal muscle cells
por: Di Lisi, Raffaella, et al.
Publicado: (2007)

A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas
por: Agnihotri, Sameer, et al.
Publicado: (2011)

Characterization of an Nmr Homolog That Modulates GATA Factor-Mediated Nitrogen Metabolite Repression in Cryptococcus neoformans
por: Lee, I. Russel, et al.
Publicado: (2012)

Correction: SUMOylation Regulates the Transcriptional Repression Activity of FOG-2 and Its Association with GATA-4
por: Perdomo, José, et al.
Publicado: (2013)

Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
por: Yang, Shujie, et al.
Publicado: (2014)

Downregulation in GATA4 and Downstream Structural and Contractile Genes in the db/db Mouse Heart
por: Broderick, Tom L., et al.
Publicado: (2012)

Afzelin attenuates asthma phenotypes by downregulation of GATA3 in a murine model of asthma
por: ZHOU, WENBO, et al.
Publicado: (2015)

GATA3 is downregulated in osteosarcoma and facilitates EMT as well as migration through regulation of slug
por: Ma, Linjie, et al.
Publicado: (2018)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sa2a9hf60fvoj72rmqqb1fkdm5